Model utworzony na podstawie danych z Min JH, Yang, H, Ivan, M, Gertler, F, Kaelin Jr, WG, Pavletich, NP. Structure of an HIF-1alpha-pVHL complex: hydroxyproline recognition in signaling. „Science”. 296. 5574, s. 1886-1889, 2002. PMID: 12004076. (PDBid=1LM8), przy wykorzystaniu MBT Protein Workshop.
Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor-Krakauer D, et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. „Nature”. 332. 6161, s. 268-269, 1988. PMID: 2894613.
Latif, F, Tory, K, Gnarra, J, Yao, M, Duh, FM, Orcutt, ML, Stackhouse, T, Kuzmin, I, Modi, W, Geil, L, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. „Science”. 260. 5112, s. 1235, 1993. PMID: 8493574.
Schoenfeld, A, Davidowitz, EJ, Burk, RD. A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor. „Proc Nat Acad Sci”. 95, s. 8817-8822, 1998. PMID: 9671762.
Iliopoulos, O, Kibel, A, Gray, S, Kaelin, WG, Jr. Tumour suppression by the human von Hippel-Lindau gene product. „Nature Medicine”. 1, s. 822-826, 1995. PMID: 7585187.
Hergovich, A, Lisztwan, J, Barry, R, Ballschmieter, P, Krek, W. Regulation of microtubule stability by the von Hippel-Lindau tumour supressor protein pVHL. „Natl Cell Biol”. 5, s. 64-70, 2003. PMID: 12510195.
Renbaum, P, Duh, FM, Latif, F, Zbar, B, Lerman, MI, Kuzmin, I. Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene. „Human Genetics”. 98. 9, s. 666-671, 1996. PMID: 8931697.
Kessler, PM. Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse
embryogenesis. „Mol Med”. 1, s. 457-466, 1995. PMID: 96091369.
Kibel, A, Iliopoulos, O, DeCaprio, JA, Kaelin, WG. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. „Science”. 269. 5229, s. 1400-1401, 1995. PMID: 7660130.
Pause A, Lee, S, Worrell, RA, Chen, DY, Burgess, WH, Linehan, WM, Klausner, RD. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. „Proc Natl Acad Sci U S A”. 94. 6, s. 2156-2161, 1997. PMID: 9122164.
Baek, JH, Liu, YV, McDonald, KR, Wesley, JB, Hubbi, ME, Byun, H, Semenza, GL. SSAT2 is an essential component of the Ubiquitin ligase complex that regulates HIF-1alpha. „J Biol Chem”. Epub, 2007. PMID: 17558023.
Maxwell, PH, Wiesener, MS, Chang, GW, Clifford, SC, Vaux, EC, Cockman, ME, Wykoff, CC, Pugh, CW, Maher, ER, Ratcliffe, PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. „Nature”. 399. 6733, s. 271-275, 1999. PMID: 10353251.
Okuda, H, Saitoh, K, Hirai, S, Iwai, K, Takaki, Y, Baba, M, Minato, N, Ohno, S, Shuin, T. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. „J Biol Chem”. 276. 47, s. 43611-43617, 2001. PMID: 11574546.
Li, Z, Wang, D, Na, X, Schoen, SR, Messing, EM, Wu, G. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. „Biochem Biophys Res Commun”. 294. 3, s. 700-709, 2002. PMID: 12056827.
Roe, J, Kim, H, Lee, S, Kim, S, Cho, E, Youn, H. p53 Stabilization and Transactivation by a von Hippel-Lindau Protein. „Molecular Cell”. 22. 3. s. 395-405. PMID: 16678111.
Aso, T, Yamazaki, K, Aigaki, T, Kitajima, S. Drosophila von Hippel-Lindau tumor suppressor complex possesses E3 ubiquitin ligase activity. „Biochem Biophys Res Commun”. 276. 1, s. 355-361, 2000. PMID: 11006129.
Stebbins, CE, Kaelin, WG, Pavletich, NP. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. „Science”. 284. 5413, s. 455-461, 1999. PMID: 10205047.
Vortmeyer, AO, et al. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. „Am J Pathol”. 151, s. 951-956, 1997. PMID: 97468663.
Vortmeyer, AO, et al. Somatic von Hippel-Lindau gene mutations detected in sporadic endolymphatic sac tumors. „Cancer Res”. 60, s. 5963-5965, 2000. PMID: 20535963.
Hoebeeck J, Vandesompele J, Nilsson H, De Preter K, Van Roy N, De Smet E, Yigit N, De Paepe A, Laureys G, Påhlman S, Speleman F. The von Hippel-Lindau tumor suppressor gene expression level has prognostic value in neuroblastoma. „Int J Cancer”. 119 (3), s. 624-629, 2006. PMID: 16506218.
AttiyehA.EFAttiyehA. i inni, Chromosome 1p and 11q deletions and outcome in neuroblastoma., „The New England journal of medicine”, 353 (21), 2005, s. 2243-53, PMID: 16306521.
W nawiasie podano alternatywną numerację – przez pewien czas niejasne było który kodon genu jest pierwszy; część badaczy numerowało nukleotydy i aminokwasy VHL od pierwszego kodonu sklonowanego cDNA (GenBank Accesion No L15409), obecnie wiadomo, że znajdującego się 71 kodonów przed kodonem start VHL; zobacz Kuzmin, I, Duh, FM, Latif, F, Geil, L, Zbar, B, Lerman, MI. Identification of the promoter of the human von Hippel-Landau disease tumor suppressor gene. „Oncogene”. 10, s. 2185-2194, 1995. PMID: 7784063.
Woodward, ER et al. Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. „Hum Mol Genet”. 6, s. 1051-1056, 1997. PMID: 97358578.
Crossey, PA, Eng, C, Ginalska-Malinowska, M, Lennard, TW, Wheeler, DC, Ponder, BA, Maher, ER. Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. „J Med Genet”. 32, s. 885-886, 1995. PMID: 8592333.
Neumann, HP, Bausch, B, McWhinney, SR, Bender, BU, Gimm, O, Franke, G, Schipper, J, Klisch, J, Altehoefer, C, Zerres, K, Januszewicz, A, Eng, C. Germ-line mutations in nonsyndromic pheochromocytoma. „New Eng J Med”. 346, s. 1459-1466, 2002. PMID: 12000816.
Pastore, Y, Jedlickova, K, Guan, Y, Liu, E, Fahner, J, Hasle, H, Prchal, JF, Prchal, JT. Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. „Am J Hum Genet”. 73, s. 412-419, 2003. PMID: 12844285.
Kanno, H, Kondo, K, Ito, S, Yamamoto, I, Fujii, S, Torigoe, S, Sakai, N, Hosaka, M, Shuin, T, Yao, M. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. „Cancer Res”. 54, s. 4845-4847, 1994. PMID: 8069849.
Gilcrease, MZ, Schmidt, L, Zbar, B, Truong, L, Rutledge, M, Wheeler, TM. Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. „Hum Path”. 26, s. 1341-1346, 1995. PMID: 8522307.
Brauch, H, Kishida, T, Glavac, D, Chen, F, Pausch, F, Hofler, H, Latif, F, Lerman, MI, Zbar, B, Neumann, HPH. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. „Hum Genet”. 95, s. 551-556, 1995. PMID: 7759077.
Bender, BU, Eng, C, Olschewski, M, Berger, DP, Laubenberger, J, Altehofer, C, Kirste, G, Orszagh, M, van Velthoven, V, Miosczka, H, Schmidt, D, Neumann, HPH. VHL c.505 T-C mutation confers a high age related penetrance but no increased overall mortality. „J Med Genet”. 38, s. 508-514, 2001. PMID: 11483638.
Neumann, HP et al. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. „JAMA”. 274,, s. 1149-1151, 1995. PMID: 96011708.
Ritter, MM et al. Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease. „J Clin Endocrinol Metab”. 81, s. 1035-1037, 1996. PMID: 96368564.